NUO THERAPEUTICS INC's ticker is AURX and the CUSIP is 67059V209. A total of 1 filers reported holding NUO THERAPEUTICS INC in Q1 2024. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,774 | -47.9% | 4,700 | 0.0% | 0.00% | – |
| Q1 2024 | $3,407 | +31.8% | 4,700 | 0.0% | 0.00% | – |
| Q4 2023 | $2,585 | -8.3% | 4,700 | 0.0% | 0.00% | – |
| Q3 2023 | $2,820 | -52.0% | 4,700 | 0.0% | 0.00% | – |
| Q2 2023 | $5,875 | -30.6% | 4,700 | 0.0% | 0.00% | – |
| Q1 2023 | $8,460 | +120757.1% | 4,700 | 0.0% | 0.00% | – |
| Q4 2022 | $7 | -99.9% | 4,700 | 0.0% | 0.00% | – |
| Q3 2022 | $13,000 | – | 4,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ancora Advisors LLC | 4,700 | $5,875 | 0.00% |